tiprankstipranks
Vicore Pharma Holding AB (DE:6Y4)
FRANKFURT:6Y4
Germany Market

Vicore Pharma Holding AB (6Y4) Technical Analysis

2 Followers

Summary of all the Indicators

Overall Consensus
Sell
7Bullish
3Neutral
12Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Vicore Pharma Holding AB’s (6Y4) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Vicore Pharma Holding AB is a Buy.
Vicore Pharma Holding AB’s (6Y4) 20-Day exponential moving average is 0.94, while Vicore Pharma Holding AB’s (6Y4) share price is €0.92, making it a Sell.
Vicore Pharma Holding AB’s (6Y4) 50-Day exponential moving average is 0.94, while Vicore Pharma Holding AB’s (6Y4) share price is €0.92, making it a Sell.

Vicore Pharma Holding AB (6Y4) Pivot Points

Jun 15, 2026, 06:57 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.86
0.86
0.86
0.86
0.86
0.86
0.86
Fibonacci
0.86
0.86
0.86
0.86
0.86
0.86
0.86
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Vicore Pharma Holding AB (6Y4) Moving Averages

Jun 15, 2026, 06:57 PM
Period
Simple
Exponential
MA5
0.90Buy
0.90Buy
MA10
0.93Sell
0.92Sell
MA20
0.97Sell
0.94Sell
MA50
0.93Sell
0.94Sell
MA100
0.93Sell
0.93Sell
MA200
0.96Sell
0.93Sell
Vicore Pharma Holding AB’s (6Y4) 10-Day exponential moving average is 0.92, while Vicore Pharma Holding AB’s (6Y4) share price is €0.92, making it a Sell.
Vicore Pharma Holding AB’s (6Y4) 100-Day exponential moving average is 0.93, while Vicore Pharma Holding AB’s (6Y4) share price is €0.92, making it a Sell.
Vicore Pharma Holding AB’s (6Y4) stock price is €0.92 and Vicore Pharma Holding AB’s (6Y4) 50-day simple moving average is 0.93, creating a Sell signal.
Vicore Pharma Holding AB’s (6Y4) stock price is €0.92 and Vicore Pharma Holding AB’s (6Y4) 100-day simple moving average is 0.93, creating a Sell signal.
Vicore Pharma Holding AB’s (6Y4) stock price is €0.92 and Vicore Pharma Holding AB’s (6Y4) 200-day simple moving average is 0.96, creating a Sell signal.

Vicore Pharma Holding AB (6Y4) Technical Indicators

Jun 15, 2026, 06:57 PM
Name
Value
Implied Action
RSI (14)
45.94
Neutral
STOCH (9,6)
8.90
Buy
STOCHRSI (14)
6.58
Buy
MACD (12,26)
-0.01
Buy
ADX (14)
15.17
Buy
Williams %R
-79.46
Buy
CCI (14)
-70.83
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
39.54
Neutral
ROC
-14.15
Sell
Vicore Pharma Holding AB’s (6Y4) Relative Strength Index (RSI) is 45.94, creating a Neutral signal.
Vicore Pharma Holding AB’s (6Y4) Trend Strength Indicator (ADX) is 15.17, creating a Buy signal.
Vicore Pharma Holding AB’s (6Y4) Commodity Channel Index (CCI) is -70.83, creating a Neutral signal.
Vicore Pharma Holding AB’s (6Y4) Price Rate of Change (ROC) is -14.15, creating a Sell signal.

FAQ

Is 6Y4 a Buy, Hold, or Sell?
Based on 6Y4’s technical indicators, 6Y4 is a Sell.
    What is 6Y4’s RSI (14)?
    6Y4’s RSI (14) is 45.94, which suggests 6Y4 is a Neutral.
      What is 6Y4’s MACD?
      6Y4’s MACD is -0.01, which suggests 6Y4 is a Buy.
        What is 6Y4’s 5-day moving average?
        6Y4’s 5-day moving average is 0.90, which suggests 6Y4 is a Buy.
          What is 6Y4’s 20-day moving average?
          6Y4 20-day moving average is 0.97, which suggests 6Y4 is a Sell.
            What is 6Y4’s 50-day moving average?
            6Y4’s 50-day moving average is 0.93, which suggests 6Y4 is a Sell.
              What is 6Y4’s 200-day moving average?
              6Y4’s 200-day moving average is 0.96, which suggests 6Y4 is a Sell.
                What is 6Y4’s Williams % R (14)?
                6Y4’s Williams % R (14) is -79.46, which suggests 6Y4 is a Buy.
                  What is 6Y4’s CCI (14)?
                  6Y4’s CCI (14) is -70.83, which suggests 6Y4 is a Neutral.
                    What is the share price of Vicore Pharma Holding AB?